다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Inspira Technologies Oxy B H N Ltd (IINN)
Inspira Technologies Oxy B H N Ltd (IINN) 뉴스

IINN

Inspira Technologies Oxy... (IINN)

Inspira Technologies Oxy B H N Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IINN

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/02	22:18	PR Newswire (US)	Inspira™ Announces Start of Production of the INSPIRA™ ART100	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/04/25	21:00	PR Newswire (US)	Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/04/16	21:42	PR Newswire (US)	Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/04/10	21:24	PR Newswire (US)	Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/04/03	21:30	PR Newswire (US)	Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/04/01	21:00	PR Newswire (US)	Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/25	22:20	PR Newswire (US)	Inspira™ Technologies Reports Full Year 2023 Financial Results	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/18	20:00	PR Newswire (US)	Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/12	21:00	PR Newswire (US)	Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/09	06:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/05	06:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/04	23:25	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/03/04	23:20	PR Newswire (US)	Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/27	21:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/27	21:02	PR Newswire (US)	Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/27	21:00	PR Newswire (US)	Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/22	23:18	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/22	21:00	PR Newswire (US)	Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/14	23:18	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/14	21:30	PR Newswire (US)	Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/13	06:05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/13	06:05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/08	23:15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/02/08	23:00	PR Newswire (US)	Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/01/30	22:40	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/01/30	22:30	PR Newswire (US)	Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/01/09	23:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/01/09	22:30	PR Newswire (US)	Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/01/02	23:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd
2024/01/02	22:30	PR Newswire (US)	Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device	NASDAQ:IINN	Inspira Technologies Oxy B H N Ltd

검색 관련기사 보기:NASDAQ:IINN

1 2 3 4 5 6 다음 >>

Bastide Le Confort Medical

Groupe Carnivor

Arena Strategic Income F...

PIMCO Flexible Emerging ...

Gabelli Global Utility & Income

Tion Renewables

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관